W28--Nutritional Breakthroughs: A Workshop on Evidenced-based Nutrition
W28.1- An evaluation of fecal metabolomics and markers of intestinal integrity in individuals with advanced cystic fibrosis liver disease (aCFLD) and the effect of Elexacaftor-Tezacaftor-Ivacaftor (ETI)